✦ LIBER ✦

First-line therapy for ovarian cancer with carboplatin followed by paclitaxel–gemcitabine (SCOTROC5): A feasibility study and comparative analysis of the SCOTROC series

✍ Scribed by Roshan Agarwal; Charlie Gourley; Timothy J. Perren; Nicholas Reed; David E. Parkin; Karen Carty; Gordon J.S. Rustin; Hani Gabra; Jim Paul; Martin E. Gore; Stanley B. Kaye

Book ID: 116430354
Publisher: Elsevier Science
Year: 2010
Tongue: English
Weight: 361 KB
Volume: 46
Category: Article
ISSN: 0959-8049
DOI: 10.1016/j.ejca.2010.03.006

No coin nor oath required. For personal study only.

📜 SIMILAR VOLUMES

SCOTROC 2B: feasibility of carboplatin f

SCOTROC 2B: feasibility of carboplatin followed by docetaxel or docetaxel–irinotecan as first-line therapy for ovarian cancer

✍ Clamp, A R; Mäenpää, J; Cruickshank, D; Ledermann, J; Wilkinson, P M; Welch, R; 📂 Article 📅 2005 🏛 Nature Publishing Group 🌐 English ⚖ 119 KB

A phase II feasibility study of carbopla

A phase II feasibility study of carboplatin followed by sequential weekly paclitaxel and gemcitabine as first-line treatment for ovarian cancer

✍ Harries, M; Moss, C; Perren, T; Gore, M; Hall, G; Everard, M; A'Hern, R; Gibbens 📂 Article 📅 2004 🏛 Nature Publishing Group 🌐 English ⚖ 112 KB

Sequential gemcitabine–carboplatin follo

Sequential gemcitabine–carboplatin followed by paclitaxel–carboplatin in the first-line treatment of advanced ovarian cancer: A phase II study

✍ Johanna U. Mäenpää; Seija E. Grénman; Jyrki T. Jalkanen; Tapio A. Kuoppala; Arto 📂 Article 📅 2006 🏛 Elsevier Science 🌐 English ⚖ 115 KB

Phase II study of carboplatin followed b

Phase II study of carboplatin followed by sequential gemcitabine and paclitaxel as first-line treatment for advanced ovarian cancer

✍ M. FRIEDLANDER; M. BUCK; D. WYLD; M. FINDLAY; B. FITZHARRIS; P. DE SOUZA; T. DAV 📂 Article 📅 2007 🏛 John Wiley and Sons 🌐 English ⚖ 125 KB

Gemcitabine and oxaliplatin followed by

Gemcitabine and oxaliplatin followed by paclitaxel and carboplatin as first line therapy for patients with suboptimally debulked, advanced epithelial ovarian cancer. A phase II trial of sequential doublets. The GO-First Study

✍ C.B. Steer; K. Chrystal; K.A. Cheong; E. Galani; G.M. Marx; A.H. Strickland; D. 📂 Article 📅 2006 🏛 Elsevier Science 🌐 English ⚖ 146 KB

A phase II study of sequential docetaxel

A phase II study of sequential docetaxel and gemcitabine followed by docetaxel and carboplatin as first-line therapy for non-small cell lung cancer

✍ Eleni M. Karapanagiotou; Adrianni Charpidou; Ifigenia Tzannou; Kalliopi Dilana; 📂 Article 📅 2008 🏛 Springer US 🌐 English ⚖ 159 KB